Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy vs Endocrine Therapy in Premenopausal Breast Cancer (NEST)
NCT01622361Phase 3Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2012
- Primary completion
- Feb 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin, tamoxifen in breast cancer, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
goserelintamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01622361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01622361.